tiprankstipranks
Trending News
More News >
10x Genomics Inc (TXG)
NASDAQ:TXG
US Market

10x Genomics (TXG) Income Statement

Compare
1,213 Followers

10x Genomics Income Statement

Last quarter (Q3 2025), 10x Genomics's total revenue was $149.00M, a decrease of -1.75% from the same quarter last year. In Q3, 10x Genomics's net income was $-27.47M. See 10x Genomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 610.78M$ 618.73M$ 516.41M$ 490.49M$ 298.85M
Gross Profit
$ 414.48M$ 409.31M$ 396.02M$ 416.40M$ 240.38M
Operating Expenses
$ 609.04M$ 674.64M$ 563.97M$ 469.31M$ 325.70M
Depreciation and Amortization
$ 43.71M$ 43.62M$ 33.01M$ 28.25M$ 19.02M
EBITDA
$ -133.99M$ -205.11M$ -128.49M$ -24.59M$ -513.77M
Operating Income
$ -194.56M$ -265.33M$ -167.94M$ -52.91M$ -85.32M
Other Income/Expenses
$ 16.86M$ 16.57M$ 5.97M$ -802.00K$ -449.15M
Pretax Income
$ -177.70M$ -248.76M$ -161.97M$ -53.72M$ -534.48M
Net Income
$ -182.63M$ -255.10M$ -166.00M$ -58.22M$ -542.73M
Per Share Metrics
Basic EPS
$ -1.52$ -2.18$ -1.46$ -0.53$ -5.37
Diluted EPS
$ -1.52$ -2.18$ -1.46$ -0.53$ -5.37
Weighted Average Shares Outstanding
120.45M 117.17M 113.86M 110.35M 101.15M
Weighted Average Shares Outstanding (Diluted)
120.45M 117.17M 113.86M 110.35M 101.15M
Currency in USD

10x Genomics Earnings and Revenue History